Wright Medical raising $260M in senior notes; Study: 72% of drugmakers rely on in-house companion Dx staff;

 @FierceMedDev: The FBI arrested two former ArthoCare execs, charging them with defrauding investors of $400M. Release | Follow @FierceMedDev

 @MarkHFierce: Faridabad in India is becoming a huge hub for medical device and equipment manufacturers. More | Follow @MarkHFierce

 @DamianFierce: CareFusion's fourth Class I recall of the summer deals with is Alaris infusion pumps. Article | Follow @DamianFierce

> Wright Medical ($WMGI) priced a $260 million cash convertible senior notes offering. Release

> Royal Philips Electronics ($PHG) will become the sole distributor of Corindus Vascular Robotics' CorPath 200 system, a robotic-assisted device to help treat obstructed coronary arteries. Release

> As many as 72% of drug manufacturers maintain a regular companion diagnostics staff, even though many companies heavily rely on outside partners to develop the technology, according to a new study. Release

> Medtronic ($MDT) has obtained a patent for "implantable medical device crosstalk evaluation and mitigation. Item

> Toshiba America Medical Systems gained FDA clearance for a new CT imaging system. Release

> GE Healthcare ($GE) is looking to get a better foothold in the Indian market by catering to the unique needs of the country's patients, the company said, keeping tabs on local product initiatives. Article

Biotech News

 @FierceBiotech: From FierceCRO: Researchers bristle at India's proposed trial reforms. Story | Follow @FierceBiotech

 @JohnCFierce: Fate Therapeutics raised a bit more than $9M for their stem cell work. Run by biotech vet Bill Rastetter. More | Follow @JohnCFierce

 @RyanMFierce: J&J is heading into Phase III with a new RA drug, add on big inflammation biz, not sure what hopes are for this one. More | Follow @RyanMFierce

> Stem cell biotech Fate nails down $9.2M. News

> ImmunoGen rises on hopes for encores to Roche's armed breast cancer drug. Story

> PRA sets up China shop with interest in Asia growing. More

Pharma News

 @FiercePharma: Thumbs up from HSBC on India's pharma sector. Dr Reddy's, Sun Pharma, Cipla are its faves--Reuters | Follow @FiercePharma

> AZ's Nexium tops Q2 sales ranks, with BMS' Abilify on its heels. Report

> Pfizer, Mylan plan joint attack on Japanese generics market. Story

Vaccines News

> Bavarian Nordic in peril if U.S. nixes smallpox vaccine order. Report

> Labs, NIH zero in on painless vaccine technology. More

> NIAID provides $7.8M in grants for HIV research. Article

> PATH Malaria Vaccine Initiative creates reference lab. Item

> Merck's Varivax slashes U.S. chickenpox cases. Story

Pharma Manufacturing News

> EU inspectors give Alexza plant the approval that FDA denied it. News

> West tapping growth in India, Asia. More

> Forfeiture of 27 ANDAs is a small piece of Ranbaxy penalties. Item

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.